Damora Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: DMRA
Share price (3/27/26): $25.50
Market cap (3/27/26): $1.538 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 120 pages Agreement and Plan of Merger by and Among: Galecto, Inc., a Delaware Corporation; Daylight Merger Sub I, Inc., a Delaware Corporation; Daylight Merger Sub II, LLC, a Delaware Limited Liability Company; and Damora Therapeutics, Inc., a Delaware Corporation Dated as of November 10, 2025

from 8-K 51 pages Asset Purchase Agreement Between Galecto, Inc. as Buyer, and Bridge Medicines LLC as Seller Dated as of October 7, 2024